Skip to main content

Table 1 Demographic and clinical characteristics of stroke patients.

From: Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke

Characteristic Good Recovery (mRS ≤ 1) Poor Recovery (mRS>1) P*
Age and Gender    
   Age, mean ± SD (yrs) 50.8 ± 9 52.5 ± 8.5 0.028
   Gender (male), n/N (%) 174/276 (63.0) 174/270 (64.4) 0.734
Past History, n/N (%)    
   Hypertension 159/241 (66.0) 143/240 (59.6) 0.147
   Diabetes 36/259 (13.9) 47/246 (19.1) 0.115
   Cardiac Disease 37/264 (14.0) 43/257 (16.7) 0.390
Sroke type, n/N (%)    
   Ischemic stroke 238/276 (86.2) 193/270 (71.5) -
   Hemorrhagic stroke 33/276 (12.0) 72/270 (26.7) -
   Unknow type of stroke 5/276 (1.8) 5/270 (1.9) -
Stroke Features, n/N (%)    
   Aphasia 53/258 (20.5) 98/250 (39.2) 4.23 × 10-6
   Neglect 11/266 (4.1) 19/240 (7.9) 0.072
   Dysphagia 15/270 (5.6) 25/251 (10.0) 0.059
   Urinary Incontinence 5/272 (1.8) 15/251 (6.0) 0.014
   Paresis 203/273 (74.4) 244/269 (90.7) 5.59 × 10-7
   Consciousness disturbance 21/275 (7.6) 59/265 (22.3) 1.72 × 10-6
   Medical complications 18/265 (6.8) 82/254 (32.3) 1.83 × 10-13
   Neurologic complications 14/274 (5.1) 39/267 (14.6) 2.03 × 10-4
  1. *Mann-Whitney test or χ2 test.
  2. SD - standard deviation, yrs - years.